Weibo Luo
Impact in
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Immunology top 2%
- T-cell and B-cell Immunology
- Psoriasis: Treatment and Pathogenesis
Papers in
-
- Cancer, Hypoxia, and Metabolism 20
- Cancer-related molecular mechanisms research 2
-
- Blood Coagulation and Thrombosis Mechanisms 7
- Erythropoietin and Anemia Treatment 1
- Co-authors
- Gregg L. Semenza (23 shared papers)Yingfei Wang (38 shared papers)Hongxia Hu (7 shared papers)Jun Zhong (4 shared papers)Akhilesh Pandey (4 shared papers)Georg Reiser (12 shared papers)Robert Norman Cole (2 shared papers)Robert N. O’Meally (2 shared papers)
- Journals
- Journal of Clinical Investigation (7 papers)Journal of Neurochemistry (5 papers)Oncotarget (5 papers)Cellular and Molecular Life Sciences (4 papers)Cancer Research (4 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Weibo Luo
91 papers receiving 8.2k citations
Weibo Luo's Hit Papers
Peers
Comparison fields: 5 of 94
- Cancer Research 1.7k
- Immunology 744
- Molecular Biology 1.2k
- Oncology 372
- Genetics 160
Countries citing papers authored by Weibo Luo
This map shows the geographic impact of Weibo Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibo Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibo Luo more than expected).
Fields of papers citing papers by Weibo Luo
This network shows the impact of papers produced by Weibo Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibo Luo. The network helps show where Weibo Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Weibo Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1 Hit paper breakdown → | 2011 | 1382 |
| 2 | Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1 Hit paper breakdown → | 2011 | 1241 |
| 3 | 2014 | 431 | |
| 4 | 2012 | 321 | |
| 5 | 2013 | 274 | |
| 6 | 2012 | 219 | |
| 7 | 2012 | 203 | |
| 8 | 2009 | 201 | |
| 9 | 2019 | 200 | |
| 10 | 2020 | 182 | |
| 11 | 2011 | 178 | |
| 12 | 2011 | 172 | |
| 13 | 2013 | 165 | |
| 14 | 2013 | 157 | |
| 15 | 2007 | 154 | |
| 16 | 2013 | 153 | |
| 17 | 2018 | 141 | |
| 18 | 2020 | 139 | |
| 19 | 2007 | 131 | |
| 20 | 2020 | 111 |
About Weibo Luo
Weibo Luo is a scholar working on Cancer Research, Hematology, Physiology, Oncology and Pulmonary and Respiratory Medicine, having authored 93 papers that have together received 8.3k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (20 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers), Asthma and respiratory diseases (3 papers), T-cell and B-cell Immunology (2 papers), Probiotics and Fermented Foods (2 papers), Liver physiology and pathology (2 papers), Cancer-related molecular mechanisms research (2 papers) and Erythropoietin and Anemia Treatment (1 paper). The work is most often cited by research in Cancer Research (1.7k citations), Immunology (744 citations), Molecular Biology (1.2k citations), Oncology (372 citations) and Genetics (160 citations). Weibo Luo has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Gregg L. Semenza, Yingfei Wang, Hongxia Hu, Jun Zhong, Akhilesh Pandey, Georg Reiser, Robert Norman Cole, Robert N. O’Meally, Matthew K. Knabel and Daniele M. Gilkes. Their work appears in journals such as Journal of Clinical Investigation, Journal of Neurochemistry, Oncotarget, Cellular and Molecular Life Sciences and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.